REGN vs TW · P/E 14, rev $14.34B vs P/E 25, rev $1.73B
Regeneron Pharmaceuticals Inc (REGN) versus Tradeweb Markets Inc (TW) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Tradeweb Markets Inc (TW) is a capital markets company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TW revenue for 2024-12-31 was $1.73B. Net income was $570.0M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. TW currently screens at market cap $21.86B and trailing P/E 24.8.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TW currently screens at market cap $21.86B and trailing P/E 24.8.
Not investment advice. Open the REGN and TW stock pages for the full models.
Not investment advice.